SCHEMBL258557

SCHEMBL258557

CCC(CC)(c1ccc(C(=O)Cl)cc1)P(=O)(O)O

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
KMT2A Q03164 1/20 0.37
HDAC1 Q13547 3/20 0.35
PGK1 P00558 1/20 0.34
PGK2 P07205 1/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
PLK1 P53350 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
PTPN1 P18031 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7870277 0.85 PGK1 (0.44) MEN1KMT2APGK1PGK2ALDH1A1
SCHEMBL6421413 0.84 MEN1 (0.38) MEN1CYP1A2KMT2AHDAC1PGK1
SCHEMBL258471 0.84 MEN1 (0.53) MEN1CYP1A2KMT2AHDAC1ALDH1A1
SCHEMBL6421418 0.83 EPHX2 (0.45) MEN1CYP1A2KMT2AALDH1A1POLB
Hydrochloric Acid SCHEMBL258558 0.83 MEN1 (0.51) MEN1CYP1A2KMT2AHDAC1ALDH1A1
SCHEMBL1354398 0.80 MEN1 (0.42) MEN1CYP1A2KMT2APGK1PGK2
SCHEMBL9440261 0.80 ALDH1A1 (0.50) MEN1KMT2AHDAC1ALDH1A1
SCHEMBL272507 0.80 MAPT (0.54) MEN1KMT2AALDH1A1POLBPTPN1
SCHEMBL5859053 0.80 PTPN5 (0.46) PGK1PGK2PTPN1
SCHEMBL8174642 0.79 CA1 (0.53) MEN1CYP1A2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8227171-B2 Photosensitive self-assembled monolayer for selective placement of hydrophilic structures INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-07-24 US disclosed
US-8057984-B2 Photosensitive self-assembled monolayer for selective placement of hydrophilic structures INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2011-11-15 US disclosed
US-20110165428-A1 PHOTOSENSITIVE SELF-ASSEMBLED MONOLAYER FOR SELECTIVE PLACEMENT OF HYDROPHILIC STRUCTURES INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2011-07-07 US disclosed
US-7888528-B2 Photosensitive self-assembled monolayer for selective placement of hydrophilic structures INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2011-02-15 US disclosed
US-20100143847-A1 PHOTOSENSITIVE SELF-ASSEMBLED MONOLAYER FOR SELECTIVE PLACEMENT OF HYDROPHILIC STRUCTURES INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2010-06-10 US disclosed
US-7732119-B2 Photosensitive self-assembled monolayer for selective placement of hydrophilic structures INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2010-06-08 US disclosed
US-20100003616-A1 PHOTOSENSITIVE SELF-ASSEMBLED MONOLAYER FOR SELECTIVE PLACEMENT OF HYDROPHILIC STRUCTURES GLOBALFOUNDRIES U.S. INC. 2010-01-07 US disclosed
US-20090098347-A1 PHOTOSENSITIVE SELF-ASSEMBLED MONOLAYER FOR SELECTIVE PLACEMENT OF HYDROPHILIC STRUCTURES GLOBALFOUNDRIES U.S. INC. 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100003616-A1 PHOTOSENSITIVE SELF-ASSEMBLED MONOLAYER FOR SELECTIVE PLACEMENT OF HYDROPHILIC STRUCTURES EPCAM, SUN2, CDH1 MEN1 2423/4885CYP1A2 1696/4885KMT2A 2369/4885
US-20090098347-A1 PHOTOSENSITIVE SELF-ASSEMBLED MONOLAYER FOR SELECTIVE PLACEMENT OF HYDROPHILIC STRUCTURES EPCAM, SUN2, CDH1 MEN1 2423/4885CYP1A2 1696/4885KMT2A 2369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.